Filing Flows › HeartSciences (HSCS) › Q1 FY26
HeartSciences (HSCS) Q1 FY26 earnings results (first quarter fiscal 2026)
10-Q filed Sep 11, 2025
HeartSciences (HSCS) reported revenue of $2K for the first quarter fiscal 2026 (Q1 FY26) and -56% from the quarter before.
HeartSciences, Q1 FY26: revenue $2K, net loss $2.1M, operating cash flow −$2.0M. The chart follows the revenue to costs, profit and cash.
| Q1 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2K | -56% | — |
| Operating profit | −$1.9M | — | — |
| Net earnings | −$2.1M | — | — |
| Operating cash flow | −$2.0M | — | — |
What changed
Revenue was $2K in Q1 FY26, down 56% from the previous quarter.
Gross margin was 60.0%. Operating costs exceeded revenue by $1.9M, an operating margin of -98637.8%. The quarter ended with a net loss of $2.1M, narrower than the previous quarter's $2.1M loss.
Operating cash flow was −$2.0M. Non-cash charges added back $7K of depreciation and $175K of share-based compensation.
Questions
What was HeartSciences' revenue in the first quarter fiscal 2026?
HeartSciences (HSCS) reported revenue of $2K for the first quarter fiscal 2026 (Q1 FY26) and -56% from the quarter before.
Source: HeartSciences 10-Q on SEC EDGAR.